Compass Therapeutics (CMPX) Interest & Investment Income (2019 - 2023)

Compass Therapeutics has disclosed Interest & Investment Income across 5 years of filings, most recently posting $2.0 million for Q4 2023.

• Interest & Investment Income for Q4 2023 came in at $2.0 million, up 52.86% year-over-year; the trailing twelve-month figure through Dec 2023 was $7.3 million (up 208.89% YoY), and the FY2023 annual result was $7.9 million, up 233.43% from the prior year.
• Interest & Investment Income came in at $2.0 million for Q4 2023 at Compass Therapeutics, up from $2.0 million in the prior quarter.
• In the past five years, Interest & Investment Income ranged from a high of $2.1 million in Q2 2023 to a low of $1000.0 in Q3 2021.
• The 5-year median for Interest & Investment Income is $176000.0 (2019), against an average of $590866.7.
• Across the five-year window, Interest & Investment Income plunged 97.05% in 2020 and soared 62200.0% in 2022, its largest moves.
• Compass Therapeutics' Interest & Investment Income stood at $176000.0 in 2019, then tumbled by 87.5% to $22000.0 in 2020, then slumped by 81.82% to $4000.0 in 2021, then jumped by 32250.0% to $1.3 million in 2022, then surged by 52.86% to $2.0 million in 2023.
• The last three Interest & Investment Income figures came in at $2.0 million (Q4 2023), $2.0 million (Q3 2023), and $2.1 million (Q2 2023), per Business Quant data.